Factors that extend the waiting period Several situations warrant waiting longer than the standard timeline: Postpartum hemorrhage or significant blood loss during delivery Preeclampsia or pregnancy-induced hypertension that has not fully resolved Active postpartum depression or anxiety that is not yet stabilized with treatment Difficulty establishing breastfeeding or low milk supply concerns Ongoing wound complications from C-section or perineal repair History of eating disorders, which GLP-1 appetite suppression could trigger Significant nutritional deficiencies identified in postpartum blood work, particularly iron deficiency anemia The American College of Obstetricians and Gynecologists has not yet issued specific guidelines on postpartum GLP-1 use, which means decisions are being made on a case-by-case basis between patients and their providers
UK approval is expected later in 2026
Available from: Lewis G, et al
Discard it safely in a sharps container and contact your prescriber or PlexusDx immediately to arrange a replacement dose before your next scheduled injection
While the net effect appears to lean toward fewer surgeries, debate persists over whether some patients might face heightened fracture risks
While not a medication, the formula is gaining recognition as a potential part of the evolving conversation around ingredient-first support for those dealing with lower back, hip, and leg discomfort